Suneeta Reddy to Sell 1.25% Stake in Apollo Hospitals for ₹1,395 Crore

Suneeta Reddy, Managing Director of Apollo Hospitals, plans to sell 1.25% of her stake in the company, worth approximately ₹1,395 crore, through block deals, according to sources familiar with the matter. The sale will involve 1.8 million shares, priced at ₹7,747 per share, a 2% discount to Apollo’s Thursday closing price of ₹7,925.

Currently, Reddy holds a 3.36% direct stake in Apollo Hospitals, which is valued at about ₹3,828 crore based on the company’s market capitalization of ₹1.14 trillion. Once the sale is completed, her holding will reduce to 2.11%. Morgan Stanley has been appointed as the broker for the transaction.

Her sisters—Preetha Reddy, Shobana Kamineni, and Sangita Reddy—hold 0.73%, 1.56%, and 1.69% stakes in the company, respectively. Interestingly, it was Suneeta Reddy who suggested the name “Apollo” for the hospital chain founded by her father, Dr. Prathap C. Reddy, in 1983.

Apollo Hospitals Financial Performance

Apollo Hospitals reported a 42% rise in net profit for the first quarter of the financial year 2025-26, reaching ₹432.8 crore, compared to ₹305.2 crore in the same period last year. The company’s consolidated revenue grew by 15%, reaching ₹5,842.1 crore, up from ₹5,085.6 crore in the previous quarter. EBITDA also saw a significant increase, rising to ₹852 crore from ₹675 crore in Q1 of FY25.

This growth was driven by strong performances across various sectors, including Healthcare Services, Retail Healthcare, Diagnostics, Digital Services, and Pharma Distribution.

As of June 30, Apollo Hospitals had 8,030 operating beds across its network (excluding AHLL and managed beds), with an overall hospital occupancy rate of 65%, compared to 68% during the same period last year.

The company also announced an ambitious growth strategy, planning to add over 4,300 beds in the next five years, with an investment of more than ₹7,600 crore. On the digital front, Apollo 24/7 reported a quarterly GMV (gross merchandise value) of over ₹682 crore, continuing its strong momentum in teleconsultations, lab services, and pharmacy deliveries.

Image Source: Wikimedia Commons | Image Credit: Respective Owner

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *